LLNI Funded Publications
We are incredibly proud of every publication that LLNI funding has contributed to.
Publishing and sharing this information and data is integral to finding answers for the future.
Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models.
Author:Crawford LJ
Other Authors: Chan ET, Aujay M, Holyoake TL, Melo JV, Jorgensen HG, Suresh S, Walker B, Irvine AE,
Last Updated:04/11/2019
Source:PubMed
Original Source:PubMed
Type:Journal Article
DOI:10.1038/oncsis.2014.3
Journal:Oncogenesis
Volume:3
Pages:e90
Date: March 2014
